Recent results identified CCND2 (cyclin D2) expression as key transmitter of RUNX–RUNX1T1-driven AML, promoting cell cycle progression with the cooperation of the transcription factor Activator protein 1 (AP-1), and suggesting new potentially targetable complexes in CBFL [14,105]. Here, RUNX1T1 is linked to acute myeloid leukemia.